Teradyne stock touches 52-week low at $82.97 amid market shifts

Published 28/03/2025, 18:12
Teradyne stock touches 52-week low at $82.97 amid market shifts

In a challenging market environment, Teradyne Inc (NASDAQ:TER) stock has recorded a new 52-week low, dipping to $82.97. The company, known for its advanced testing solutions for semiconductors and electronic systems, has faced headwinds that have pressured its stock price over the past year. According to InvestingPro data, analyst price targets range from $81 to $155, suggesting significant potential upside despite current market conditions. The company maintains strong fundamentals with a healthy current ratio of 2.91x and a solid 20% return on equity. Investors have witnessed a significant downturn in Teradyne’s market valuation, with the stock experiencing a 1-year change of -26.28%. This decline reflects broader market trends and specific industry challenges that have affected the company’s performance and investor sentiment. InvestingPro analysis reveals the stock is currently trading below its Fair Value, with 8 additional exclusive tips available to subscribers who want to dive deeper into Teradyne’s investment potential.

In other recent news, Teradyne has faced a series of adjustments in its financial outlook from various analysts. The company announced a revised financial guidance, indicating a downturn in the June quarter with an expected 5% decrease, contrasting with earlier forecasts of growth. This change is largely due to challenges in the semiconductor testing segment, including tariff impacts and export restrictions affecting China memory. Northland Securities, TD Cowen, UBS, Stifel, and KeyBanc Capital Markets have all revised their price targets for Teradyne, citing various near-term challenges but maintaining positive long-term outlooks.

Northland Securities lowered its target to $105 while keeping an Outperform rating, highlighting tariff uncertainties. TD Cowen and Stifel both adjusted their targets to $110, with TD Cowen maintaining a Buy rating and Stifel holding a Hold rating, indicating cautious optimism. UBS reduced its target to $130, maintaining a Buy rating, and noted operational expense reductions as a strategic response to current market conditions. KeyBanc Capital Markets adjusted its target to $140, keeping an Overweight rating, and expressed optimism about Teradyne’s future performance despite potential macroeconomic delays.

Analysts have noted Teradyne’s strategic initiatives in areas like Industrial Automation and AI, which are expected to drive long-term growth. Despite the challenges, the consistent Buy ratings from several firms suggest confidence in Teradyne’s ability to navigate current headwinds and capitalize on future opportunities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.